Janux Therapeutics, Inc. Common Stock vs. Johnson & Johnson
Janux Therapeutics, Inc. Common Stock and Johnson & Johnson are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JANX | JNJ | |
|---|---|---|
| Market Cap | $1.08 billion | $664.95 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JANX | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.90% |
JANX and JNJ split the dividend factors evenly.
Risk & Sentiment
| JANX | JNJ | |
|---|---|---|
| Short Interest | 0.65% | 0.67% |
JANX leads on 1 of 1 risk & sentiment factors.
Dig deeper: JANX overview, JANX financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.